Tempo Therapeutics
A regenerative-medicine company developing injectable microporous scaffolds that help the body rebuild tissue at damaged sites.
$14.5MFunding
ParticipantYB
YK Bioventures
Activity from announced rounds
Activity in this selectionOct 17, 2026 · Sep 18, 2026
YK Bioventures is the life-sciences venture firm whose own profile identifies Think Bio, Vivere, Moonwalk and Tempo.
Recorded funding activity
Think develops small-molecule medicines. Moonwalk targets fat-tissue pathways, while Tempo develops regenerative scaffolds. These programs pursue distinct therapeutic mechanisms within the recorded activity.
Sources
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $14.5M 1 disclosed · full round size, not this investor’s share